Takeover of Cubist Pharmaceuticals Inc (NASDAQ:CBST) Faces Investor Investigation

Takeover of Cubist Pharmaceuticals Inc (NASDAQ:CBST) Faces Investor Investigation

The Shareholders Foundation announces that an investigation on behalf of investors, who currently hold shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST), was launched concerning whether the takeover of Cubist Pharmaceuticals Inc by Merck for $102 per share is unfair to NASDAQ:CBST stockholders. Investors who purchased shares … Continue Reading →
Vascular Solutions, Inc. (NASDAQ:VASC) Investor Alert: Investigation over Potential Wrongdoing

Vascular Solutions, Inc. (NASDAQ:VASC) Investor Alert: Investigation over Potential Wrongdoing

An investigation on behalf of current long-term investors in shares of Vascular Solutions, Inc. (NASDAQ:VASC) shares was announced over potential breaches of fiduciary duties by certain officers and directors at Vascular Solutions. Investors who purchased shares of Vascular Solutions, Inc. (NASDAQ:VASC) have certain options and … Continue Reading →
Relmada Therapeutics Appoints Christine Silverstein as Director of Investor Relations

Relmada Therapeutics Appoints Christine Silverstein as Director of Investor Relations

Relmada Therapeutics, Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today that it has appointed Christine Silverstein as director of investor relations, effective immediately. She will report to Michael Becker, senior vice president of finance and corporate development at … Continue Reading →